March 2023
2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Posters
March 2023
European Society for Medical Oncology Targeted Anticancer Therapies (ESMO TAT) Congress
Safety and efficacy results of SRK-181 (a latent TGFβ1 inhibitor) from a phase 1 trial (DRAGON trial)
November 2022
American College of Toxicology Annual Meeting 2022
Selective Latent TGFβ1 Inhibitors Exhibits Improved Nonclinical Safety Profile
November 2022
Poster Hall
SRK-181, a latent TGFβ1 inhibitor: safety, efficacy, and biomarker results from the dose escalation portion of a phase I trial (DRAGON trial) in patients with advanced solid tumors
October 2022
International Scientific Congress on SMA
Apitegromab in SMA: Efficacy, Safety and PK/PD Assessments in 24 Months of TOPAZ
October 2022
WMS Hybrid Congress